0001689813-19-000066.txt : 20190919
0001689813-19-000066.hdr.sgml : 20190919
20190919210500
ACCESSION NUMBER: 0001689813-19-000066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190917
FILED AS OF DATE: 20190919
DATE AS OF CHANGE: 20190919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stock Elyse
CENTRAL INDEX KEY: 0001785732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 191102573
BUSINESS ADDRESS:
BUSINESS PHONE: (203) 404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
wf-form4_156894148158568.xml
FORM 4
X0306
4
2019-09-17
0
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001785732
Stock Elyse
C/O BIOHAVEN PHARMACEUTICALS, INC., 215
CHURCH STREET
NEW HAVEN
CT
06510
0
1
0
0
Chief Medical Officer
Employee Stock Option (Right to Buy)
47.32
2019-09-17
4
A
0
11000
0
A
2029-09-16
Common Shares
11000.0
11000
I
By Spouse
The option became exercisable with respect to 2,750 of the shares underlying the option on the grant date (September 17, 2019), and the remaining 8,250 shares underlying the option vest in three equal installments on September 17, 2020, 2021 and 2022, subject to the optionholder's continuous service with the issuer as of each applicable vesting date.
This stock option is held by the reporting person's spouse, who is a consultant for the issuer.
/s/ Jim Engelhart, Attorney-in-fact
2019-09-19